PTPRC and neoplasm: Flow cytometry analysis showed that E7 RNA-LPX/LRT treatment induces cell death of tumor cells and hence increases the tumor infiltration of total CD45+ cells and CD8+T cells, but does not change the fraction of vaccine-induced E7-specific CD8+T cells among CD8+T cells, when compared to E7 RNA-LPX-treated mice (Fig. 4b).